Hyperuricemia

Corticosteroids Compared for Pre-Infusion Prophylaxis in Patients Receiving Pegloticase for Gout

Publish Date December 13, 2019

Compared with intravenous hydrocortisone, IV methylprednisolone appears to be more beneficial as a pre-infusion prophylaxis therapy in patients receiving pegloticase, according to the findings of a recently published review.

Lower Risk for Gout With SGLT2 Inhibitors vs GLP1 Agonists in Type 2 Diabetes

Publish Date November 21, 2019

Researchers assessed the risk for gout among adults receiving a sodium-glucose cotransporter 2 inhibitor vs a glucagon-like peptide-1 receptor agonist.

Uncontrolled Gout Ups All-Cause, CV Mortality

Publish Date October 31, 2019

There is increasing evidence to support lower serum uric acid thresholds of at least 6 mg/dL in patients with gout to improve survival.

Addressing Physician Education to Improve Patient Outcomes in Gout

Publish Date October 31, 2019

Dr Brian LaMoreaux emphasized the importance of screening, addressing manifestations, and physician education in improving patient outcomes in gout.

Vaccines May Increase Risk for Gout Flares, But Benefits of Vaccination Outweigh Risks

Publish Date October 25, 2019

Are patients with gout more likely to experience a flare in the days following vaccination?

DECT-Detected Cardiovascular Monosodium Urate Deposits More Common in Patients With Gout

Publish Date October 15, 2019

Researchers assessed coronary calcium score and cardiovascular monosodium urate deposits detected by dual-energy computed tomography in patients with gout vs healthy controls.

Gout Risk During Tuberculosis Treatment Higher With Obesity, Chronic Kidney Disease, Hyperuricemia

Publish Date October 4, 2019

Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.

Chronic Kidney Disease Progression, Recovery Common in Patients With Gout Using Urate-Lowering Drugs

Publish Date October 1, 2019

Researchers investigated the association between exposure to urate-lowering drugs and the progression and recovery of chronic kidney disease in patients with gout.

Heart Disease May Up Risk for Allopurinol-Linked Cutaneous AEs

Publish Date September 30, 2019

Risk for hospital admission increased for allopurinol-associated severe cutaneous adverse reactions

Canagliflozin May Reduce Gout-Related Adverse Events, Uric Acid Levels in T2D

Publish Date September 18, 2019

Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.